Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
7.74M
-
Number of holders
-
17
-
Total shares
-
2.13M
-
Shares change
-
+1.8M
-
Total reported value, excl. options
-
$915K
-
Value change
-
+$791K
-
Number of buys
-
13
-
Number of sells
-
-2
-
Price
-
$0.43
Significant Holders of Kazia Therapeutics Limited - American Depositary Shares (KZIA) as of Q3 2024
filings reported holding KZIA - Kazia Therapeutics Limited - American Depositary Shares as of Q3 2024.
Kazia Therapeutics Limited - American Depositary Shares (KZIA) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.13M shares
of 7.74M outstanding shares and own 27.5% of the company stock.
Largest 10 shareholders include MAI Capital Management (1.36M shares), UBS Group AG (249K shares), MORGAN STANLEY (220K shares), CITADEL ADVISORS LLC (60.5K shares), JANE STREET GROUP, LLC (46.1K shares), UNITED BANK (44K shares), JPMORGAN CHASE & CO (37.8K shares), COMMONWEALTH EQUITY SERVICES, LLC (30.5K shares), RHUMBLINE ADVISERS (27.8K shares), and XTX Topco Ltd (23.4K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.